During this interval, your body is given the time it needs to clear, or wash out, the previous treatment so it is less likely to influence how the next medicine works
Gastrointestinal side effects are the most frequently reported adverse reactions with GLP-1 receptor agonists, particularly during the initial weeks of treatment or following dose escalation
The DSIP-CBBBP and DSIP groups demonstrates the most substantial increase in neuron density, indicating a highly significant difference compared to the model group ( p = 0.007 and 0.013, respectively)
The medicine slows gastric emptying what used to feel like a normal portion may now feel like overeating, and overeating while on a GLP-1 medicine can produce predictable nausea and discomfort
In same study, treatment with potent inhibitor of PKR 2-aminopurine resulted in the reduction of apoptotic population by more than 50%
14 (InTechOpen, 2012)